Bayforest Capital Ltd Has $111,000 Stock Holdings in Cigna Group $CI

Key Points

• Bayforest Capital Ltd has significantly reduced its stake in Cigna Group, decreasing its holdings by 91.8% to 337 shares valued at $111,000.
• Other institutional investors such as Price T Rowe Associates and Valeo Financial Advisors have increased their positions in Cigna Group, highlighting ongoing confidence in the company's stock.
• Cigna Group recently announced a $1.51 quarterly dividend, yielding 2.0%, alongside strong earnings performance with a reported EPS of $7.20 in the last quarter.

Bayforest Capital Ltd decreased its position in shares of Cigna Group (NYSE:CI - Free Report) by 91.8% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 337 shares of the health services provider's stock after selling 3,775 shares during the quarter. Bayforest Capital Ltd's holdings in Cigna Group were worth $111,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of CI. Price T Rowe Associates Inc. MD raised its position in shares of Cigna Group by 10.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider's stock valued at $3,966,690,000 after acquiring an additional 1,094,327 shares during the last quarter. Massachusetts Financial Services Co. MA raised its position in shares of Cigna Group by 0.9% during the 1st quarter. Massachusetts Financial Services Co. MA now owns 11,654,993 shares of the health services provider's stock valued at $3,834,493,000 after acquiring an additional 98,715 shares during the last quarter. Dodge & Cox raised its position in shares of Cigna Group by 1.3% during the 1st quarter. Dodge & Cox now owns 8,889,733 shares of the health services provider's stock valued at $2,924,722,000 after acquiring an additional 117,125 shares during the last quarter. GQG Partners LLC raised its position in shares of Cigna Group by 21.5% during the 1st quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider's stock valued at $1,607,716,000 after acquiring an additional 865,092 shares during the last quarter. Finally, Valeo Financial Advisors LLC raised its position in shares of Cigna Group by 86,071.1% during the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider's stock valued at $1,148,859,000 after acquiring an additional 3,471,249 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company's stock.

Insider Transactions at Cigna Group

In other news, insider Nicole S. Jones sold 28,526 shares of the stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the transaction, the insider directly owned 25,648 shares in the company, valued at $7,694,400. This represents a 52.66% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Brian C. Evanko sold 5,368 shares of the stock in a transaction dated Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the transaction, the insider owned 51,182 shares of the company's stock, valued at approximately $15,354,600. This represents a 9.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.70% of the stock is currently owned by corporate insiders.

Cigna Group Price Performance

CI stock opened at $299.81 on Friday. The stock has a 50-day moving average price of $297.27 and a two-hundred day moving average price of $308.29. The stock has a market cap of $80.03 billion, a PE ratio of 16.37, a price-to-earnings-growth ratio of 0.85 and a beta of 0.45. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. Cigna Group has a 1 year low of $256.89 and a 1 year high of $353.55.

Cigna Group (NYSE:CI - Get Free Report) last released its earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $7.15 by $0.05. The firm had revenue of $67.13 billion during the quarter, compared to analysts' expectations of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company's revenue was up 11.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th were issued a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date was Thursday, September 4th. Cigna Group's dividend payout ratio is 32.97%.

Analysts Set New Price Targets

Several analysts have commented on CI shares. Deutsche Bank Aktiengesellschaft set a $415.00 target price on shares of Cigna Group and gave the company a "buy" rating in a research report on Tuesday, August 5th. Wells Fargo & Company upped their target price on shares of Cigna Group from $340.00 to $354.00 and gave the company an "equal weight" rating in a research report on Tuesday, October 7th. Cantor Fitzgerald restated an "overweight" rating and issued a $365.00 price objective on shares of Cigna Group in a research report on Tuesday, August 26th. Wolfe Research lowered their price objective on shares of Cigna Group from $345.00 to $325.00 and set an "outperform" rating for the company in a research report on Wednesday. Finally, Weiss Ratings restated a "hold (c+)" rating on shares of Cigna Group in a research report on Wednesday, October 8th. Two analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat.com, Cigna Group presently has a consensus rating of "Moderate Buy" and a consensus price target of $369.89.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.